GlassScriptPhysician profile
David C Chaikin
NPI 1750374823
$51,184.34
in general payments reported to CMS, 2019-2025
38 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $2,768 · 2021: $221 · 2022: $2,155 · 2023: $617 · 2024: $408 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $3,064 · Food and Beverage: $2,316 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,500.00 |
| Travel and Lodging | $3,064.22 |
| Food and Beverage | $2,316.32 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $24,539.84 | 2025 | |
| Merck Sharp & Dohme LLC | $13,918.34 | 2019-2023 | Lynparza, Welireg, Keytruda |
| Abbvie INC. | $5,254.45 | 2019-2025 | Botox, Lupron Depot |
| Integra Gpo, LLC | $3,755.34 | 2019 | |
| Procept Biorobotics Corporation | $1,786.67 | 2022 | |
| Caldera Medical, INC | $200.74 | 2023 | Desara |
| Telix Pharmaceuticals | $189.03 | 2024-2025 | Illuccix |
| Astellas Pharma US INC | $159.12 | 2019-2023 | Veozah |
| Ferring Pharmaceuticals INC. | $158.28 | 2024 | Adstiladrin |
| Medtronic, INC. | $156.13 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $139.82 | 2019-2023 | |
| Pfizer INC. | $122.57 | 2019-2024 | |
| Edap Technomed INC | $100.00 | 2023 | |
| Janssen Biotech, INC. | $95.52 | 2021-2024 | Erleada |
| Urogen Pharma, INC. | $88.39 | 2022-2024 | Jelmyto |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $58.75 | 2021-2022 | |
| Agiliti Surgical, INC. | $46.86 | 2023 | Sonablate, Trinity |
| Allergan, INC. | $43.26 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Ethicon US, LLC | $34.76 | 2025 | Echelon Flex |
| Bluewind Medical | $33.01 | 2024 | |
| Olympus America INC. | $30.89 | 2022-2025 | Itind System |
| Immunitybio, INC. | $19.34 | 2025 | |
| Tolmar, INC. | $18.84 | 2025 | Jatenzo, Eligard |
| Neotract INC. | $18.80 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.88 | 2024 | |
| Coloplast Corp | $17.35 | 2019 | |
| Myovant Sciences INC. | $16.89 | 2022 | |
| Photocure INC | $16.37 | 2024 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $16.16 | 2025 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $14.93 | 2023 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $14.70 | 2019 | |
| Glaxosmithkline, LLC. | $14.58 | 2022 | |
| Urovant Sciences INC | $14.27 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.39 | 2019 | |
| Bioprotect Medical, INC. | $13.18 | 2024 | Bioprotect Balloon Implant System |
| Eisai INC. | $10.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chaikin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.